Alnylam Pharmaceuticals, Inc. (ALNY): Capital Expenditures
$58.70M
Year ended 2025-12-31
$91.95M
Trailing 12 months to 2026-06-30
-6.6%
3-year compound annual growth
-3.6%
5-year compound annual growth
+16.3%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $58.70M | +71.2% | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | $34.28M | -44.9% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $62.21M | -13.7% | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | $72.06M | -5.6% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $76.37M | +8.5% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $70.36M | -49.8% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $140.16M | +10.5% | 2022-02-10, From 2019-01-01 |
| 2018-12-31 | $126.89M | +21.8% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $104.21M | +61.4% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $64.56M | +398.5% | 2019-02-14, From 2016-01-01 |
| 2015-12-31 | $12.95M | +44.5% | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | $8.96M | +123.7% | 2017-02-15, From 2014-01-01 |
| 2013-12-31 | $4.01M | -52.0% | 2016-02-12, From 2013-01-01 |
| 2012-12-31 | $8.35M | +546.6% | 2015-02-13, From 2012-01-01 |
| 2011-12-31 | $1.29M | -72.7% | 2014-02-20, From 2011-01-01 |
| 2010-12-31 | $4.73M | -4.4% | 2013-02-19, From 2010-01-01 |
| 2009-12-31 | $4.95M | -54.0% | 2012-02-13, From 2009-01-01 |
| 2008-12-31 | $10.76M | n/a | 2011-02-18, From 2008-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $58.70M | +71.2% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $93.40M | -21.0% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $58.75M | +54.3% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $103.04M | +20.6% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $520.50M | +111.2% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $70.06M | +34.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $276.00M | +87.8% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $185.84M | -62.3% |
| Organon & Co. (OGN) | 2025-12-31 | $162.00M | -7.4% |
Compare ALNY, PRGO, JAZZ, BMRN side by side · Screen every company in Pharmaceutical Preparations ↗